![](https://cdn.benzinga.com/files/images/story/2024/07/25/Analysts.png?width=1200&height=800&fit=crop)
These Analysts Slash Their Forecasts On Edwards Lifesciences Following Q2 Results
Edwards Lifesciences Corporation EW reported worse-than-expected second-quarter sales results and issued third-quarter guidance below estimates. Also, the company acquired JenaValve and Endotronix. Edwards Lifesciences reported quarterly earnings of 70 …